prenatal exposure

Exposure to Antidepressants During Pregnancy: Less Impact on Long Term Outcomes Than Previously Reported

Rommel and colleagues present a systematic review examining the long-term effects of prenatal exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes in children 4 years of age or older. 

By |2022-02-09T09:23:33-04:00May 28th, 2020|Pregnancy & Medications|Comments Off on Exposure to Antidepressants During Pregnancy: Less Impact on Long Term Outcomes Than Previously Reported

Prenatal SSRI Exposure and Speech/Language Disorders: Many Headlines, Little Risk

Last week, an article looking at the cognitive and motor development of children with prenatal exposure to antidepressants was published in JAMA Psychiatry.  Since that time, we have received a lot of questions regarding the [...]

By |2020-11-26T08:31:57-04:00October 21st, 2016|Pregnancy & Medications|Comments Off on Prenatal SSRI Exposure and Speech/Language Disorders: Many Headlines, Little Risk

Prenatal Exposure to Levetiracetam and Topiramate: No Evidence of Cognitive Deficits

Many of the newer antiepileptic drugs (AEDs) have uses beyond the treatment of epilepsy.  Topiramate (marketed as a Topamax), in addition to its use for the treatment of epilepsy, is now being prescribed to reproductive [...]

By |2016-10-03T11:24:32-04:00October 3rd, 2016|Pregnancy & Medications|Comments Off on Prenatal Exposure to Levetiracetam and Topiramate: No Evidence of Cognitive Deficits

Accumulating Data on Prenatal Exposure to SSRIs

November, 2006 by LEE COHEN, M.D. Over the last year, several studies on possible neonatal effects of prenatal exposure to SSRIs have been reviewed in this column. These studies have raised concerns about potential risks, [...]

By |2020-12-11T12:38:11-04:00April 29th, 2008|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Accumulating Data on Prenatal Exposure to SSRIs
Go to Top